ESTIMATE analysis showed that CD180 was significantly positively correlated with stromal score, immune score, and ESTIMATE score, but negatively correlated with tumor purity, suggesting the potential role of CD180 in TME (Fig. 5A). This evidence concerns the gene CD180 and neoplasm.